Pd33-07 differences in utilization of non-first-line therapy for overactive bladder among fpmrs and non-fpmrs trained urologists

Aaron Huang, Arshia Harandi, Jennifer Ramgopal, Jonathan Aronov, Philip Fonseca, Holly Smith, Brian Shkolnik, Inna Tabanskaya, Connelly Miller,Jason Kim

The Journal of Urology(2023)

引用 0|浏览0
暂无评分
摘要
You have accessJournal of UrologyCME1 Apr 2023PD33-07 DIFFERENCES IN UTILIZATION OF NON-FIRST-LINE THERAPY FOR OVERACTIVE BLADDER AMONG FPMRS AND NON-FPMRS TRAINED UROLOGISTS Aaron Huang, Arshia Harandi, Jennifer Ramgopal, Jonathan Aronov, Philip Fonseca, Holly Smith, Brian Shkolnik, Inna Tabanskaya, Connelly Miller, and Jason Kim Aaron HuangAaron Huang More articles by this author , Arshia HarandiArshia Harandi More articles by this author , Jennifer RamgopalJennifer Ramgopal More articles by this author , Jonathan AronovJonathan Aronov More articles by this author , Philip FonsecaPhilip Fonseca More articles by this author , Holly SmithHolly Smith More articles by this author , Brian ShkolnikBrian Shkolnik More articles by this author , Inna TabanskayaInna Tabanskaya More articles by this author , Connelly MillerConnelly Miller More articles by this author , and Jason KimJason Kim More articles by this author View All Author Informationhttps://doi.org/10.1097/JU.0000000000003326.07AboutPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissionsReprints ShareFacebookLinked InTwitterEmail Abstract INTRODUCTION AND OBJECTIVE: Overactive bladder (OAB) is a disease entity that greatly affects a patient’s quality of life, with some studies citing a prevalence as high as 40% in the United States. The American Urological Association and Society of Urodynamics, Female Pelvic Medicine & Urogenital Reconstruction describe a progressive management of OAB from first to third line therapies (second line being pharmacotherapy and third line being procedural intervention). The objective of this study is to expand on the differences in utilization of non-first line therapy for OAB between Female Pelvic Medicine and Reconstructive Surgery (FPMRS) trained urologists and non-FPMRS trained urologists. METHODS: We reviewed the records of all adult female patients seen in our urology clinic for OAB symptoms from July 2020 to June 2021. Patients were classified into two groups: (1) those who were first seen by an FPMRS-trained urologist and (2) those who were not. Patient demographics, relevant clinical history, and choice of OAB therapy were also collected from the electronic medical record. Chi-squared tests, t-tests and univariate logistic regression were used to compare the characteristics of patients who were and were not seen by FPMRS-trained urologists. RESULTS: Eight hundred sixteen patients were included in this study, of which six hundred sixty three patients (81.3%) were first seen by a FPMRS-trained urologist. No demographic differences were found between the two groups. There were significantly more patients that proceeded to both second (OR 2.44, CI 1.66-3.58, p<0.001) and third-line therapy (OR 6.98, CI 2.14-22.79, p<0.001) within a year when they were first seen by FPMRS-trained providers. More patients that were first seen by FPMRS-trained providers also had incontinence more often than those seen by non-FPMRS trained urologists (Table 1). CONCLUSIONS: Patients that were first seen by FPMRS urologists were 2 times more likely to proceed to second-line therapy and nearly 7 times more likely to proceed to third-line therapy for OAB within a year when compared to those seen by their non-FPMRS-trained counterparts. This finding suggests that non-FPMRS trained urologists may be providing suboptimal treatment of OAB and necessitates further study. Source of Funding: None © 2023 by American Urological Association Education and Research, Inc.FiguresReferencesRelatedDetails Volume 209Issue Supplement 4April 2023Page: e916 Advertisement Copyright & Permissions© 2023 by American Urological Association Education and Research, Inc.MetricsAuthor Information Aaron Huang More articles by this author Arshia Harandi More articles by this author Jennifer Ramgopal More articles by this author Jonathan Aronov More articles by this author Philip Fonseca More articles by this author Holly Smith More articles by this author Brian Shkolnik More articles by this author Inna Tabanskaya More articles by this author Connelly Miller More articles by this author Jason Kim More articles by this author Expand All Advertisement PDF downloadLoading ...
更多
查看译文
关键词
overactive bladder,non-first-line,non-fpmrs
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要